Series D funding round for Alder Biopharmaceuticals raising $38M in April 2012
Series D funding round for Alder Biopharmaceuticals raising $38M in April 2012
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$78M
Top Valuation
-
Alder Biopharmaceuticals raised $38M in a Series D round.
The round was announced on 04/01/12.